% Expired Patents = 100.0

Forward Citations = 20

Loading Chart...

4 inventors (with patents filed for the assignee):

Charles E Seeney (4 out of 8 patents)

Kenneth J Dormer (3 out of 10 patents)

William A Yuill (1 out of 11 patents)

4. Richard Dana Kopke (1 out of 14 patents)

4 patents: Sort by Forward Citations

1. 8001977 - Device for moving magnetic nanoparticles through tissue (2011-08-23),

2. 7819795 - Method and apparatus for improving hearing (2010-10-26),

3. 7723311 - Delivery of bioactive substances to target cells (2010-05-25),

4. 7344491 - Method and apparatus for improving hearing (2008-03-18),

Company Overview

Nanobiomagnetics, Inc. is a leading biotechnology company specializing in the development of magnetic nanoparticles for various applications in healthcare and life sciences. Our innovative technology enables precise targeting and delivery of therapeutic agents, diagnostics, and imaging tools at the molecular level. With a focus on precision medicine and personalized healthcare, we are committed to advancing the field of nanomedicine through groundbreaking research and partnerships with leading academic and industry collaborators.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#81 in Oklahoma City, OK

#331 in Oklahoma

#60,597 in US

Oklahoma City, OK, United States of America

Nanobiomagnetics, Inc.

Forward Citations = 20

4 inventors:

Charles E Seeney (4 out of 8 patents)

Kenneth J Dormer (3 out of 10 patents)

William A Yuill (1 out of 11 patents)

4. Richard Dana Kopke (1 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanobiomagnetics, Inc.. Retrieved from https://idiyas.com/company/nanobiomagnetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]